DR TB patient support programme overview

People diagnosed with any form of DR-TB (rifampicin mono-resistant, multi-drug resistant [MDR] and extensively resistant [XDR and pre-XDR] tuberculosis) embark on a two year treatment journey.

On this journey, most patients receive an intramuscular injection, along with a combination of oral medicines, on a daily basis for at least six months.